{"id":"https://openalex.org/W2035208607","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","title":"Actions of cocaine on rat nucleus accumbens neuronesin vitro","display_name":"Actions of cocaine on rat nucleus accumbens neuronesin vitro","alternate_titles":[],"publication_year":1990,"publication_date":"1990-04-01","ids":{"openalex":"https://openalex.org/W2035208607","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","mag":"2035208607","pmid":"https://pubmed.ncbi.nlm.nih.gov/2193689","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1917561"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1990.tb12999.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb12999.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2035208607"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb12999.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090481309","display_name":"Naohisa Uchimura","orcid":"https://orcid.org/0000-0002-9177-4049","observed_orcids":["https://orcid.org/0000-0002-9177-4049"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2802707198","display_name":"Vollum Institute","ror":"https://ror.org/054hm6j14","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802707198"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N. Uchimura","raw_affiliation_strings":["Vollum Institute, Oregon Health Sciences University, Portland 97201","Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201, U. S. A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vollum Institute, Oregon Health Sciences University, Portland 97201","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2802707198"]},{"raw_affiliation_string":"Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201, U. S. A","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2802707198"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084712627","display_name":"Richard Alan North","orcid":"https://orcid.org/0000-0001-9783-1094","observed_orcids":["https://orcid.org/0000-0001-9783-1094"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I2802707198","display_name":"Vollum Institute","ror":"https://ror.org/054hm6j14","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802707198"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R.A. North","raw_affiliation_strings":["Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201, U.S.A","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I2802707198"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.1443,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.87387888,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"99","issue":"4","first_page":"736","last_page":"740"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine","display_name":"cocaine","score":1.0},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.902999997138977},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.5590000152587891},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.781000018119812},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.7699999809265137},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":1.0},{"id":"https://openalex.org/keywords/neuronal-membrane-potential","display_name":"neuronal membrane potential","score":0.6019999980926514},{"id":"https://openalex.org/keywords/dopamine-reuptake-inhibition","display_name":"dopamine uptake inhibition","score":0.5580000281333923},{"id":"https://openalex.org/keywords/serotonin-uptake-inhibition","display_name":"serotonin uptake inhibition","score":0.9700000286102295},{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":0.6430000066757202},{"id":"https://openalex.org/keywords/sch-23390","display_name":"SCH 23390","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.8265600800514221},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.8165044188499451},{"id":"https://openalex.org/C2780806966","wikidata":"https://www.wikidata.org/wiki/Q422418","display_name":"Sulpiride","level":4,"score":0.6707005500793457},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6089111566543579},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.557344913482666},{"id":"https://openalex.org/C2908949072","wikidata":"https://www.wikidata.org/wiki/Q899647","display_name":"Dopamine Uptake Inhibitors","level":4,"score":0.5126680135726929},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5005555152893066},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.46483445167541504},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46365341544151306},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4542473256587982},{"id":"https://openalex.org/C181911157","wikidata":"https://www.wikidata.org/wiki/Q389844","display_name":"Membrane potential","level":2,"score":0.4507482349872589},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.449624627828598},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3264263868331909},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.262894868850708},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23573532700538635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1796618103981018},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10094991326332092}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012686","descriptor_name":"Septal Nuclei","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1990.tb12999.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb12999.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1917561","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1917561","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:2193689","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2193689","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1990.tb12999.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb12999.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1990.tb12999.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.7246000170707703,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3352790721","display_name":"PHARMACOLOGICAL REGULATION OF DOPAMINE NEURONAL ACTIVITY","funder_award_id":"R01MH040416","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G5668097070","display_name":null,"funder_award_id":"DA03160","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7241952532","display_name":"OPIATE ACTIONS ON SINGLE BRAIN NEURONS IN VITRO","funder_award_id":"R01DA003161","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2035208607.pdf","grobid_xml":"https://content.openalex.org/works/W2035208607.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W221359381","https://openalex.org/W1006537507","https://openalex.org/W1581666194","https://openalex.org/W1932079514","https://openalex.org/W1964847468","https://openalex.org/W1970734636","https://openalex.org/W1977486844","https://openalex.org/W1981264895","https://openalex.org/W2003497480","https://openalex.org/W2020460680","https://openalex.org/W2026812180","https://openalex.org/W2036260773","https://openalex.org/W2040959946","https://openalex.org/W2059639890","https://openalex.org/W2061161259","https://openalex.org/W2095217951","https://openalex.org/W2167381827","https://openalex.org/W2246813284","https://openalex.org/W2415483373","https://openalex.org/W2416279662","https://openalex.org/W4301963125","https://openalex.org/W7049043835"],"related_works":["https://openalex.org/W2003497480","https://openalex.org/W1795329520","https://openalex.org/W2062061883","https://openalex.org/W1842924802","https://openalex.org/W2030516903","https://openalex.org/W2099703466","https://openalex.org/W2057636933","https://openalex.org/W2056412954","https://openalex.org/W2095056388"],"abstract_inverted_index":{"1.":[0],"Intracellular":[1],"recordings":[2],"were":[3,64,120,137],"made":[4],"from":[5,125],"103":[6],"neurones":[7,24,39],"of":[8,55,62,74,86,96,150,159,172,178,184,197],"the":[9,60,110,122,170,195],"rat":[10,179],"nucleus":[11,180],"accumbens":[12],"in":[13,19,34,94,176,193],"vitro.":[14],"2.":[15],"Dopamine":[16],"(3-100":[17,32],"microM;":[18,33],"sulpiride,":[20],"1":[21,36,145,188],"microM)":[22,37,48,108,128,189],"hyperpolarized":[23],"(79%)":[25],"by":[26,41,66],"acting":[27,42],"at":[28,43,153],"D1":[29],"receptors:":[30],"dopamine":[31,56,114,173],"SCH23390,":[35],"depolarized":[38,49],"(55%)":[40],"D2":[44],"receptors.":[45],"5-Hydroxytryptamine":[46],"(1-100":[47],"86%":[50],"neurones.":[51],"3.":[52],"Both":[53],"actions":[54],"as":[57,59,84],"well":[58],"effect":[61,73],"5-hydroxytryptamine":[63,136,175],"potentiated":[65],"cocaine":[67,144,166,185],"(0.3-30":[68],"microM),":[69],"which":[70],"had":[71],"no":[72],"its":[75],"own":[76],"on":[77],"membrane":[78],"potential.":[79],"4.":[80],"Dose-ratio":[81],"was":[82],"computed":[83],"[(concentration":[85],"agonist":[87,97],"causing":[88,98],"a":[89,99,148,157],"4":[90,100],"mV":[91,101],"potential":[92,102],"change":[93,103],"cocaine)/(concentration":[95],"without":[104],"cocaine)].":[105],"Cocaine":[106],"(1-30":[107],"caused":[109],"same":[111],"dose-ratio":[112,123,149,158],"whether":[113],"depolarizations":[115],"(D2)":[116],"or":[117],"hyperpolarizations":[118],"(D1)":[119],"measured;":[121],"ranged":[124],"2":[126],"(1":[127],"to":[129,135,142,168,187],"50":[130],"(30":[131],"microM).":[132],"5.":[133],"Responses":[134],"increased":[138],"more":[139],"than":[140],"responses":[141],"dopamine;":[143],"microM":[146,155],"gave":[147,156],"13.4":[151],"and":[152,174],"30":[154],"118.":[160],"6.":[161],"It":[162],"is":[163],"concluded":[164],"that":[165],"acts":[167],"inhibit":[169],"uptake":[171],"slices":[177],"accumbens;":[181],"lower":[182],"concentrations":[183],"(0.3":[186],"are":[190],"particularly":[191],"effective":[192],"potentiating":[194],"action":[196],"5-hydroxytryptamine.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2035208607","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
